Code | 24873 | ||||||||||
MA number | 46/0661/95-S | ||||||||||
Product Form: | cps dur 100x10 mg (blis.PVC/PVDC) | ||||||||||
MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
Type of procedure: | National | ||||||||||
MAH, country: | Teva B.V., Netherland | ||||||||||
Therapeutic Class: | 46 - DERMATOLOGICA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 36 | ||||||||||
Container: | blister PVC/PVDC | ||||||||||
Route of admin.: | Oral use |
Prescription Status: | Medicinal product subject to medical prescription. |
Legal basis: | Article 8(3) application - new active substance |
MA issued: | 30.10.1995 |
Pediatric indication: | Yes |
Pediatric posology: | Yes |
Pediatric warnings: | Yes |
PIL: | PIL_Neotigason_10 mg_25 mg_02.2024.pdf |
SPC: | SPC_Neotigason_10 mg_25 mg_02.2024.pdf |
Dokument: | retinoidy_Kontrolny zoznam pre lekarnika.pdf |
Dokument: | retinoidy_Karta pacienta_pacientky.pdf |
Dokument: | retinoidy_Kontrolny zoznam pre lekara a potvrdzujuci formular pacientky.pdf |
Dokument: | DHPC_retinoidy_07.06.2024.pdf |
Safety feature | Yes |
Data update: | 30.05.2018 |